Selinexor in combination with dexamethasone with or without bortezomib in heavily pretreated multiple myeloma: A case series.

This report describes the characteristics and outcomes of 18 heavily pretreated patients with multiple myeloma (MM) who were subsequently treated with selinexor. This is a case series of 18 patients with MM who were treated with selinexor and dexamethasone (Sd) or selinexor, bortezomib, and dexamethasone (SVd) in 12 hospitals in the UK between 2019 and 2021. Eight patients received Sd and 10 patients received SVd.

Bed-sharing influences, attitudes, and practices: implications for promoting safe infant sleep.

The purpose of this study was to examine the infant bed-sharing practices of mothers from the birth of the infant to three months of age. The study was a longitudinal descriptive design using a self-report instrument immediately after delivery with follow-up phone interviews at one and three months after discharge. While no mothers intended to bed-share with their infants immediately after delivery, 60 percent reported bed-sharing at some time at one month after discharge and 9 percent at three months.